Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-07

AUTHORS

Sasha Mazzarello, Brian Hutton, Mohammed F. K. Ibrahim, Carmel Jacobs, Risa Shorr, Stephanie Smith, Terry Ng, Mark Clemons

ABSTRACT

Symptoms of urogenital atrophy are common in breast cancer survivors. Its optimal management is currently unknown. A systematic review of randomized controlled trials (RCTs) evaluating treatments for urogenital atrophy in breast cancer patients was performed. EMBASE, Ovid Medline and the Cochrane Library were searched from 1946 to November 2014. Outcomes included improvements in both vaginal symptoms (e.g., dryness, pain, dyspareunia and itching) and vaginal hormone response measured by validated scales [e.g., Vaginal Health Index (VHI) and Vaginal Maturation Index (VMI)]. Of 430 unique citations identified, 4 studies (n = 196) met inclusion criteria. Interventions included pH-balanced gel, Replens(®), lidocaine, Estring(®) and Vagifem(®). Sample sizes ranged from 7 to 98 patients. Given the heterogeneity of the studies, a narrative synthesis of results was performed. One study of 98 patients suggested that vaginal pH-balanced gel (mean VHI 5.00 ± 0.816, mean VMI 51.18 ± 3.753) was more efficient than placebo (VHI 16.98 ± 3.875, p < 0.001, VMI 47.87 ± 2.728, p < 0.001) at 12 weeks in providing vaginal symptom relief. In patients who used lidocaine, 90 % had reduced dyspareunia compared to saline in a study of 46 patients. Although increased serum estradiol occurred, both Estring(®) and Vagifem(®) were shown to improve quality of life and VMI in a study of seven patients. Treatment of urogenital atrophy remains a challenging issue and there is a paucity of RCT evidence addressing this knowledge gap. It is evident that more prospective trials are needed. More... »

PAGES

1-8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z

DOI

http://dx.doi.org/10.1007/s10549-015-3434-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002984615

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26003182


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrophy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Management", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female Urogenital Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mazzarello", 
        "givenName": "Sasha", 
        "id": "sg:person.0737376756.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hutton", 
        "givenName": "Brian", 
        "id": "sg:person.01235465321.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ibrahim", 
        "givenName": "Mohammed F. K.", 
        "id": "sg:person.012754470322.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012754470322.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jacobs", 
        "givenName": "Carmel", 
        "id": "sg:person.01036635505.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036635505.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "The Ottawa Hospital, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shorr", 
        "givenName": "Risa", 
        "id": "sg:person.01016010441.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016010441.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Stephanie", 
        "id": "sg:person.0651052101.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651052101.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ng", 
        "givenName": "Terry", 
        "id": "sg:person.01132237041.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132237041.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ottawa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412687.e", 
          "name": [
            "Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada", 
            "Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clemons", 
        "givenName": "Mark", 
        "id": "sg:person.01216107435.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejca.2012.07.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001308924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2007-0234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004135901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61963-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006312031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5122(95)00956-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006921450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-45769-2_38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014853163", 
          "https://doi.org/10.1007/978-3-642-45769-2_38"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0b013e3182118790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020833086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0b013e3182118790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020833086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0b013e3182118790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020833086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/13697137.2012.756466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021288676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.maturitas.2011.09.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022379007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)15493-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026400310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/dji071", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030054143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd001500.pub2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031034848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0000000000000203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031629013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0000000000000203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031629013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006263818115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032185952", 
          "https://doi.org/10.1023/a:1006263818115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajog.2010.08.035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033350385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/gme.0b013e31816c5541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033603119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/gme.0b013e31816c5541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033603119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.d5928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041893471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-005-0847-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041959587", 
          "https://doi.org/10.1007/s00520-005-0847-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-005-0847-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041959587", 
          "https://doi.org/10.1007/s00520-005-0847-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-005-0847-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041959587", 
          "https://doi.org/10.1007/s00520-005-0847-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clon.2012.06.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043854024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70341-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048840099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/cbc.2009.n.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052388473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/13697137.2010.522875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052625955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem.87.1.8141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064324808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.3.969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083057210"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-07", 
    "datePublishedReg": "2015-07-01", 
    "description": "Symptoms of urogenital atrophy are common in breast cancer survivors. Its optimal management is currently unknown. A systematic review of randomized controlled trials (RCTs) evaluating treatments for urogenital atrophy in breast cancer patients was performed. EMBASE, Ovid Medline and the Cochrane Library were searched from 1946 to November 2014. Outcomes included improvements in both vaginal symptoms (e.g., dryness, pain, dyspareunia and itching) and vaginal hormone response measured by validated scales [e.g., Vaginal Health Index (VHI) and Vaginal Maturation Index (VMI)]. Of 430 unique citations identified, 4 studies (n = 196) met inclusion criteria. Interventions included pH-balanced gel, Replens(\u00ae), lidocaine, Estring(\u00ae) and Vagifem(\u00ae). Sample sizes ranged from 7 to 98 patients. Given the heterogeneity of the studies, a narrative synthesis of results was performed. One study of 98 patients suggested that vaginal pH-balanced gel (mean VHI 5.00 \u00b1 0.816, mean VMI 51.18 \u00b1 3.753) was more efficient than placebo (VHI 16.98 \u00b1 3.875, p < 0.001, VMI 47.87 \u00b1 2.728, p < 0.001) at 12 weeks in providing vaginal symptom relief. In patients who used lidocaine, 90 % had reduced dyspareunia compared to saline in a study of 46 patients. Although increased serum estradiol occurred, both Estring(\u00ae) and Vagifem(\u00ae) were shown to improve quality of life and VMI in a study of seven patients. Treatment of urogenital atrophy remains a challenging issue and there is a paucity of RCT evidence addressing this knowledge gap. It is evident that more prospective trials are needed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10549-015-3434-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "152"
      }
    ], 
    "name": "Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials", 
    "pagination": "1-8", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0e368d6bf9a23c9f779b528f12f9499550d3ebe24dbfff15c9666893dc889299"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26003182"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8111104"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10549-015-3434-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002984615"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10549-015-3434-z", 
      "https://app.dimensions.ai/details/publication/pub.1002984615"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10549-015-3434-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      21 PREDICATES      59 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-015-3434-z schema:about N0f2189acdeda4321a2d29b589c1a93e9
2 N1174b13d6ee54c6ebc2158228247afa3
3 N2083ff092b0e47db91227998ec0b623b
4 N28d38394207e4e9d8a3dc52bda0b585c
5 N714877be56984138a77d2ef49b28838f
6 N99c5adb4f3a94cf69d8cc0645543873e
7 Nb8c72efdae5c44d19d7fb6b0e50c31e0
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author N3e51519f26fd4d99aa2587d0c85a0237
11 schema:citation sg:pub.10.1007/978-3-642-45769-2_38
12 sg:pub.10.1007/s00520-005-0847-y
13 sg:pub.10.1023/a:1006263818115
14 https://doi.org/10.1002/14651858.cd001500.pub2
15 https://doi.org/10.1016/0378-5122(95)00956-6
16 https://doi.org/10.1016/j.ajog.2010.08.035
17 https://doi.org/10.1016/j.clon.2012.06.009
18 https://doi.org/10.1016/j.ejca.2012.07.003
19 https://doi.org/10.1016/j.maturitas.2011.09.003
20 https://doi.org/10.1016/s0140-6736(04)15493-7
21 https://doi.org/10.1016/s0140-6736(12)61963-1
22 https://doi.org/10.1016/s1470-2045(08)70341-3
23 https://doi.org/10.1093/jnci/dji071
24 https://doi.org/10.1097/aog.0000000000000203
25 https://doi.org/10.1097/aog.0b013e3182118790
26 https://doi.org/10.1097/gme.0b013e31816c5541
27 https://doi.org/10.1136/bmj.d5928
28 https://doi.org/10.1200/jco.1997.15.3.969
29 https://doi.org/10.1210/jcem.87.1.8141
30 https://doi.org/10.1634/theoncologist.2007-0234
31 https://doi.org/10.3109/13697137.2010.522875
32 https://doi.org/10.3109/13697137.2012.756466
33 https://doi.org/10.3816/cbc.2009.n.020
34 schema:datePublished 2015-07
35 schema:datePublishedReg 2015-07-01
36 schema:description Symptoms of urogenital atrophy are common in breast cancer survivors. Its optimal management is currently unknown. A systematic review of randomized controlled trials (RCTs) evaluating treatments for urogenital atrophy in breast cancer patients was performed. EMBASE, Ovid Medline and the Cochrane Library were searched from 1946 to November 2014. Outcomes included improvements in both vaginal symptoms (e.g., dryness, pain, dyspareunia and itching) and vaginal hormone response measured by validated scales [e.g., Vaginal Health Index (VHI) and Vaginal Maturation Index (VMI)]. Of 430 unique citations identified, 4 studies (n = 196) met inclusion criteria. Interventions included pH-balanced gel, Replens(®), lidocaine, Estring(®) and Vagifem(®). Sample sizes ranged from 7 to 98 patients. Given the heterogeneity of the studies, a narrative synthesis of results was performed. One study of 98 patients suggested that vaginal pH-balanced gel (mean VHI 5.00 ± 0.816, mean VMI 51.18 ± 3.753) was more efficient than placebo (VHI 16.98 ± 3.875, p < 0.001, VMI 47.87 ± 2.728, p < 0.001) at 12 weeks in providing vaginal symptom relief. In patients who used lidocaine, 90 % had reduced dyspareunia compared to saline in a study of 46 patients. Although increased serum estradiol occurred, both Estring(®) and Vagifem(®) were shown to improve quality of life and VMI in a study of seven patients. Treatment of urogenital atrophy remains a challenging issue and there is a paucity of RCT evidence addressing this knowledge gap. It is evident that more prospective trials are needed.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree false
40 schema:isPartOf N716cb20c703d4fd9be9a71e96c83ca31
41 Nb0b2c365db1f48bebf162e1812071660
42 sg:journal.1092777
43 schema:name Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials
44 schema:pagination 1-8
45 schema:productId N10cb3fb9dc5a4d158952eb84af850fd0
46 N2091c1296e68405392643f4605da4855
47 N3db4ab6a2a8e4b10bb5e66f29af8d4d4
48 Nd049706142234d19ba38d9750aba17e2
49 Ned160c6323714f888bdc76d3aa86ad7d
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002984615
51 https://doi.org/10.1007/s10549-015-3434-z
52 schema:sdDatePublished 2019-04-10T23:23
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N31043f7fa7c04c44b98ef16c4eddc4a3
55 schema:url http://link.springer.com/10.1007%2Fs10549-015-3434-z
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N004b2879f2844eaa9994f32e180eae40 schema:name Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada
60 rdf:type schema:Organization
61 N064beea0ea9d4fb697805c5460b1b263 schema:name Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada
62 rdf:type schema:Organization
63 N0f2189acdeda4321a2d29b589c1a93e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Atrophy
65 rdf:type schema:DefinedTerm
66 N10cb3fb9dc5a4d158952eb84af850fd0 schema:name pubmed_id
67 schema:value 26003182
68 rdf:type schema:PropertyValue
69 N1174b13d6ee54c6ebc2158228247afa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Humans
71 rdf:type schema:DefinedTerm
72 N2083ff092b0e47db91227998ec0b623b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Female Urogenital Diseases
74 rdf:type schema:DefinedTerm
75 N2091c1296e68405392643f4605da4855 schema:name dimensions_id
76 schema:value pub.1002984615
77 rdf:type schema:PropertyValue
78 N28d38394207e4e9d8a3dc52bda0b585c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Disease Management
80 rdf:type schema:DefinedTerm
81 N2c677f5737534c599643a02662cc4906 schema:name Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada
82 rdf:type schema:Organization
83 N31043f7fa7c04c44b98ef16c4eddc4a3 schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 N3db4ab6a2a8e4b10bb5e66f29af8d4d4 schema:name nlm_unique_id
86 schema:value 8111104
87 rdf:type schema:PropertyValue
88 N3e51519f26fd4d99aa2587d0c85a0237 rdf:first sg:person.0737376756.24
89 rdf:rest N6873a94665c74e72ada62be5d36c8968
90 N657d9329b442461d98eed7bdf9be308e rdf:first sg:person.0651052101.37
91 rdf:rest Ne28c9dd9cb0c449e8672d796b5d38969
92 N6873a94665c74e72ada62be5d36c8968 rdf:first sg:person.01235465321.38
93 rdf:rest Naf7716f91e6e42a78f7fa19408ea94b3
94 N6b8af38fe7e945c39b382f3a544e54cf rdf:first sg:person.01036635505.66
95 rdf:rest Na259230636b540fc93e646e501cc934a
96 N714877be56984138a77d2ef49b28838f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Breast Neoplasms
98 rdf:type schema:DefinedTerm
99 N716cb20c703d4fd9be9a71e96c83ca31 schema:issueNumber 1
100 rdf:type schema:PublicationIssue
101 N99c5adb4f3a94cf69d8cc0645543873e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Female
103 rdf:type schema:DefinedTerm
104 Na259230636b540fc93e646e501cc934a rdf:first sg:person.01016010441.99
105 rdf:rest N657d9329b442461d98eed7bdf9be308e
106 Naf7716f91e6e42a78f7fa19408ea94b3 rdf:first sg:person.012754470322.02
107 rdf:rest N6b8af38fe7e945c39b382f3a544e54cf
108 Nb0b2c365db1f48bebf162e1812071660 schema:volumeNumber 152
109 rdf:type schema:PublicationVolume
110 Nb8c72efdae5c44d19d7fb6b0e50c31e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Randomized Controlled Trials as Topic
112 rdf:type schema:DefinedTerm
113 Nd049706142234d19ba38d9750aba17e2 schema:name doi
114 schema:value 10.1007/s10549-015-3434-z
115 rdf:type schema:PropertyValue
116 Ne28c9dd9cb0c449e8672d796b5d38969 rdf:first sg:person.01132237041.41
117 rdf:rest Ne85bdea195424c46ac3af527cc30b4f0
118 Ne85bdea195424c46ac3af527cc30b4f0 rdf:first sg:person.01216107435.90
119 rdf:rest rdf:nil
120 Ned160c6323714f888bdc76d3aa86ad7d schema:name readcube_id
121 schema:value 0e368d6bf9a23c9f779b528f12f9499550d3ebe24dbfff15c9666893dc889299
122 rdf:type schema:PropertyValue
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
127 schema:name Clinical Sciences
128 rdf:type schema:DefinedTerm
129 sg:journal.1092777 schema:issn 0167-6806
130 1573-7217
131 schema:name Breast Cancer Research and Treatment
132 rdf:type schema:Periodical
133 sg:person.01016010441.99 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
134 schema:familyName Shorr
135 schema:givenName Risa
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016010441.99
137 rdf:type schema:Person
138 sg:person.01036635505.66 schema:affiliation N2c677f5737534c599643a02662cc4906
139 schema:familyName Jacobs
140 schema:givenName Carmel
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036635505.66
142 rdf:type schema:Person
143 sg:person.01132237041.41 schema:affiliation N064beea0ea9d4fb697805c5460b1b263
144 schema:familyName Ng
145 schema:givenName Terry
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132237041.41
147 rdf:type schema:Person
148 sg:person.01216107435.90 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
149 schema:familyName Clemons
150 schema:givenName Mark
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90
152 rdf:type schema:Person
153 sg:person.01235465321.38 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
154 schema:familyName Hutton
155 schema:givenName Brian
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38
157 rdf:type schema:Person
158 sg:person.012754470322.02 schema:affiliation N004b2879f2844eaa9994f32e180eae40
159 schema:familyName Ibrahim
160 schema:givenName Mohammed F. K.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012754470322.02
162 rdf:type schema:Person
163 sg:person.0651052101.37 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
164 schema:familyName Smith
165 schema:givenName Stephanie
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651052101.37
167 rdf:type schema:Person
168 sg:person.0737376756.24 schema:affiliation https://www.grid.ac/institutes/grid.412687.e
169 schema:familyName Mazzarello
170 schema:givenName Sasha
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24
172 rdf:type schema:Person
173 sg:pub.10.1007/978-3-642-45769-2_38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014853163
174 https://doi.org/10.1007/978-3-642-45769-2_38
175 rdf:type schema:CreativeWork
176 sg:pub.10.1007/s00520-005-0847-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1041959587
177 https://doi.org/10.1007/s00520-005-0847-y
178 rdf:type schema:CreativeWork
179 sg:pub.10.1023/a:1006263818115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032185952
180 https://doi.org/10.1023/a:1006263818115
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1002/14651858.cd001500.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031034848
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/0378-5122(95)00956-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006921450
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.ajog.2010.08.035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033350385
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.clon.2012.06.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043854024
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ejca.2012.07.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001308924
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.maturitas.2011.09.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022379007
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/s0140-6736(04)15493-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026400310
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/s0140-6736(12)61963-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006312031
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/s1470-2045(08)70341-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048840099
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1093/jnci/dji071 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030054143
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1097/aog.0000000000000203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031629013
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1097/aog.0b013e3182118790 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020833086
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1097/gme.0b013e31816c5541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033603119
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1136/bmj.d5928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041893471
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1200/jco.1997.15.3.969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083057210
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1210/jcem.87.1.8141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064324808
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1634/theoncologist.2007-0234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004135901
215 rdf:type schema:CreativeWork
216 https://doi.org/10.3109/13697137.2010.522875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052625955
217 rdf:type schema:CreativeWork
218 https://doi.org/10.3109/13697137.2012.756466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021288676
219 rdf:type schema:CreativeWork
220 https://doi.org/10.3816/cbc.2009.n.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052388473
221 rdf:type schema:CreativeWork
222 https://www.grid.ac/institutes/grid.412687.e schema:alternateName Ottawa Hospital
223 schema:name Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada
224 Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada
225 Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada
226 The Ottawa Hospital, Ottawa, Canada
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...